<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Evidence supporting the contribution of <z:mp ids='MP_0003674'>oxidative stress</z:mp> to key pathways in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, such as <z:mp ids='MP_0001845'>inflammation</z:mp> and DNA damage, continues to mount </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated variations within genes mediating <z:mp ids='MP_0003674'>oxidative stress</z:mp> to determine whether they alter risk for non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) </plain></SENT>
<SENT sid="2" pm="."><plain>Thirteen single nucleotide polymorphisms (SNPs) from 10 <z:mp ids='MP_0003674'>oxidative stress</z:mp> genes (AKR1A1, AKR1C1, CYBA, GPX, MPO, NOS2A, NOS3, OGG1, PPARG and SOD2) were genotyped in 1172 NHL cases and 982 population-based controls from a USA multicenter case-control study </plain></SENT>
<SENT sid="3" pm="."><plain>For NHL and five subtypes (diffuse large B-cell, follicular, marginal zone, small lymphocytic and T-cell), SNP associations were calculated </plain></SENT>
<SENT sid="4" pm="."><plain>Odds ratios (OR) and 95% confidence intervals (CI) were adjusted for sex, age (&lt;45, 45-64, 65+ years), race (white, black, other) and study site </plain></SENT>
<SENT sid="5" pm="."><plain>Overall, the <z:mp ids='MP_0003674'>oxidative stress</z:mp> pathway was associated significantly with the B-cell NHL subtype, diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) (global P-value=0.003) </plain></SENT>
<SENT sid="6" pm="."><plain>Specifically, for nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (NOS2A Ser608Leu, rs2297518) Leu/Leu homozygotes, there was a 2-fold risk increase for NHL (OR=2.2, 95% CI=1.1-4.4) (referent=Ser/Ser and Ser/Leu) </plain></SENT>
<SENT sid="7" pm="."><plain>This risk increase was consistent by cell lineage (B- and T-cell NHL) and pronounced for the two most common subtypes, diffuse large B-cell (OR=3.4, 95% CI=1.5-7.8) and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (OR=2.6, 95% CI=1.0-6.8) </plain></SENT>
<SENT sid="8" pm="."><plain>In an analysis of <z:chebi fb="70" ids="18291,35154">manganese</z:chebi> <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD2 Val16Ala, rs1799725) Ala/Ala homozygotes, we observed moderately increased risks for B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (OR=1.3, 95% CI=1.0-1.6; referent=Val/Val and Val/Ala) that was consistent across the B-cell subtypes </plain></SENT>
<SENT sid="9" pm="."><plain>Genetic variations that result in an increased generation of reactive oxygen species appear to increase risk for NHL and its major subtypes, particularly <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Independent replication of our findings are warranted and further evaluation of <z:mp ids='MP_0003674'>oxidative stress</z:mp> in the context of <z:mp ids='MP_0001845'>inflammation</z:mp>, DNA repair and the induction of the NF-kappaB pathway may further reveal important clues for <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
</text></document>